|4Mar 26, 7:35 PM ET

Patrick Todd 4

4 · Armata Pharmaceuticals, Inc. · Filed Mar 26, 2021

Insider Transaction Report

Form 4
Period: 2021-03-25
Patrick Todd
DirectorChief Executive Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-03-25+112,000112,000 total
    Exercise: $5.14Exp: 2031-03-25Common Stock (112,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to twenty-five percent (25%) of the underlying shares of common stock on each of the first, second, third and fourth annual anniversaries of the date of grant.

Documents

1 file
  • 4
    tm2111079-3_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT